• Mirko Scherer, CEO, CoFeS China
Dr. Scherer is CEO of CoFeS China and Cofes France. CoFeS’ mission is to facilitate licensing, investments, and partnerships between innovative Western life science companies and Chinese investors and companies. Mirko is co-located in Hong Kong and Paris. Previously he worked for several years with the life science investment firms MPM Capital and TVM Capital in various consulting and advisory functions. Prior to working in the VC and advisory business, Mirko co-founded GPC Biotech (Munich and Princeton, NJ) and served as its Chief Financial Officer for a decade. GPC Biotech engaged in numerous pharmaceutical alliances with companies such as Sanofi Aventis, Boehringer Ingelheim, Altana (now part of Takeda), Yakult and Pharmion (now part of Celgene). At GPC, Mirko was responsible for all financial, legal, corporate communication and governance topics. He was instrumental in numerous capital raisings (venture capital stage, IPO and follow on offerings in Germany as well as on NASDAQ), licensing transactions, mergers & acquisitions and other strategic transactions. Over the last 20 years Mirko has established an extensive network in the European, Chinese, and North American pharma, biotechnology and venture capital industries. Prior to his time at GPC Biotech Mirko worked as a consultant at the Boston Consulting Group. He has served on the Board of the Frankfurt Stock Exchange, Stichting Preferente Aandelen QIAGEN, as well as Quantapore Inc., and is currently a board member of Aptorum Inc. Mirko holds an MBA from Harvard Business School, Boston. He also earned a Doctorate in Finance from the European Business School in Oestrich-Winkel/Germany and a degree in business administration from the University of Mannheim/Germany.